Johns Hopkins Bloomberg School of Public Health (JHSPH)
Located in Baltimore, USA, the Johns Hopkins Bloomberg School of Public Health is the largest institution of public health research, education, and professional practice in the world. It is part of the Johns Hopkins University, the first research-based university in the United States. The JHSPH has a commitment to excellence in research that has demonstrated impact on the performance of health systems and on national and international policy. Its Health Systems Programme (HSP) is widely recognised as a centre of international excellence in health policy, health systems analysis, health economics, epidemiology, public health, health education, and research and evaluation methodologies. JHSPH has a number of longstanding partnerships with institutions in Africa and Asia and a commitment to multi-disciplinary research on health system development.
Who we work with at JHSPH
- Dr Sara Bennett, CEO Future Health Systems (FHS publications, JHSPH profile, Google Scholar profile)
- Dr David Peters, Research Director Future Health Systems (FHS publications, JHSPH profile)
- Dr Adnan Hyder (FHS publications, JHSPH profile)
- Dr David Bishai (FHS publications, JHSPH profile, Google Scholar profile)
- Dr Anbrasi Edward (FHS publications, JHSPH profile)
- Md. Hafizur Rahman (FHS publications, JHSPH profile)
- Dr Ligia Paina (FHS publications, JHSPH profile)
- Dr Daniela Rodriguez (FHS publications, JHSPH profile)
- Dr Olakunle O. Alonge (FHS Publications, JHSPH profile)
Recent FHS publications involving JHSPH
Glandon D, Paina L, Alonge O, Peters DH and Bennett S (2017) 10 Best resources for community engagement in implementation research, Health Policy and Planning, Volume 32, Issue 10, 1457–1465, doi: 10.1093/heapol/czx123
Implementation research (IR) focuses on understanding how and why interventions produce their effects in a given context. This often requires engaging a broad array of stakeholders at multiple levels of the health system. Whereas a variety of tools and approaches exist to facilitate stakeholder engagement at the national or institutional level, there is a substantial gap in the IR literature about how best to do this at the local or community level. Similarly, although there is extensive guidance on community engagement within the context of clinical trials—for HIV/AIDS in particular—the same cannot be said for IR. We identified a total of 59 resources by using a combination of online searches of the peer-reviewed and grey literature, as well as crowd-sourcing through the Health Systems Global platform. The authors then completed two rounds of rating the resources to identify the ‘10 best’.
Bloom G, Berdou E, Standing H, Guo Z and Labrique A (2017) ICTs and the challenge of health system transition in low and middle-income countries, Globalization and Health, 13:56, doi: 10.1186/s12992-017-0276-y
The aim of this paper is to contribute to debates about how governments and other stakeholders can influence the application of ICTs to increase access to safe, effective and affordable treatment of common illnesses, especially by the poor. First, it argues that the health sector is best conceptualized as a ‘knowledge economy’. This supports a broadened view of health service provision that includes formal and informal arrangements for the provision of medical advice and drugs. This is particularly important in countries with a pluralistic health system, with relatively underdeveloped institutional arrangements. It then argues that reframing the health sector as a knowledge economy allows us to circumvent the blind spots associated with donor-driven ICT-interventions and consider more broadly the forces that are driving e-health innovations. It draws on small case studies in Bangladesh and China to illustrate new types of organization and new kinds of relationship between organizations that are emerging. It argues that several factors have impeded the rapid diffusion of ICT innovations at scale including: the limited capacity of innovations to meet health service needs, the time it takes to build new kinds of partnership between public and private actors and participants in the health and communications sectors and the lack of a supportive regulatory environment. It emphasises the need to understand the political economy of the digital health knowledge economy and the new regulatory challenges likely to emerge. It concludes that governments will need to play a more active role to facilitate the diffusion of beneficial ICT innovations at scale and ensure that the overall pattern of health system development meets the needs of the population, including the poor.
Pratt B, Allen KA and Hyder AA (2016) Promoting equity through health systems research in low- and middle-income countries: Practices of researchers, AJOB Empirical Bioethics, Volume 7, Issue 3, DOI:10.1080/23294515.2015.1122669
Health systems research is increasingly identified as an indispensable means to achieve the goal of health equity between and within countries. While conceptual work has explored what form of health systems research in low and middle-income countries (LMICs) is needed to promote health equity, there have been few attempts to investigate whether it is being performed in practice. This paper describes the results of a survey undertaken with health systems researchers worldwide to assess how equity-oriented current practice is in LMICs.